Kraft Heinz Co vs Sanofi SA — how do they compare? Kraft Heinz Co trades at $25.9 (market cap $30.66B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 3.4× Kraft Heinz Co's market cap, and Kraft Heinz Co pays the higher dividend (6.19%). Which is the better fit depends on your goals.
| KHC | SNY | |
|---|---|---|
Market Cap | $30.66B | $104.83B |
Sector | Consumer Staples | Health |
52-Week High | $28.94 | $52.34 |
52-Week Low | $21.21 | $41.33 |
Enterprise Value | $47.71B | $121.32B |
Dividend Yield | 6.19% | 5.5% |
Trailing returns across standard periods
Latest headlines on both assets
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →